Physician profile
David Holladay
NPI 1962472936
$1,288.91
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $62.55 · 2022: $339 · 2023: $495 · 2024: $22.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $296.61 | 2020-2023 | |
| Duchesnay USA Incorporated | $191.74 | 2019 | |
| Pfizer INC. | $137.22 | 2019-2023 | |
| Daiichi Sankyo INC. | $112.17 | 2022-2024 | Injectafer |
| Exeltis, USA INC. | $98.24 | 2022-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $52.28 | 2019-2023 | |
| Exact Sciences Corporation | $49.32 | 2023 | Cologuard Collection Kit |
| Myovant Sciences INC. | $40.36 | 2022 | |
| Astellas Pharma US INC | $34.61 | 2019-2020 | |
| Dexcom, INC. | $27.83 | 2023 | Dexcom G6 Transmitter |
| Coopersurgical, INC. | $26.31 | 2019-2023 | Paragard T 380a |
| Novo Nordisk INC | $26.22 | 2019 | |
| Amag Pharmaceuticals, INC. | $25.87 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.92 | 2022 | |
| Aspira Women'S Health INC | $19.47 | 2023 | Ova1 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $17.47 | 2022 | |
| Avion Pharmaceuticals | $17.21 | 2022 | |
| Sumitomo Pharma America, INC. | $17.08 | 2023 | Myfembree |
| Amgen INC. | $17.04 | 2023 | Prolia, Evenity |
| Agile Therapeutics, INC. | $14.91 | 2022 | |
| Shield Therapeutics INC | $13.25 | 2023 | Accrufer |
| Ferring Pharmaceuticals INC. | $11.75 | 2019 | |
| Meditrina | $11.21 | 2023 | |
| Coloplast Corp | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Holladay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.